
Sharda Cropchem Q4 FY26 Results: PAT Rs 318.6 Crore Up 56 Percent YoY Revenue Rs 2064.9 Crore FY26 Annual PAT Rs 681 Crore Up 124 Percent Dividend Rs 9
Thu May 14 2026

Sharda Cropchem Q4 FY26 results were announced on 13 May 2026. Sharda Cropchem Q4 FY26 consolidated PAT rose 56% YoY to Rs 318.6 crore on revenue of Rs 2,064.9 crore (+13% YoY). Agrochemicals segment revenue Rs 1,926.8 crore, profit Rs 379.9 crore. FY26 full-year performance was record-breaking: PAT surged 124% to Rs 681 crore from Rs 304.4 crore in FY25, revenue up 22% to Rs 5,267.6 crore. Gross margin expanded 600bps to 35.9%. EBITDA Rs 1,040 crore (+69% YoY). Active registrations 3,011 across 80+ countries. Board recommended final dividend of Rs 9/share. FY26 EPS Rs 75.47 vs Rs 33.74. Investors tracking Sharda Cropchem Q4 FY26 results will find detailed financial data, analysis, and FY27 outlook in this article.
Click Here – Get Free Investment Predictions
Sharda Cropchem Q4 FY26 Key Financial Highlights
| Parameter | Q4 FY26 | Reference |
|---|---|---|
| Net Profit (PAT) | Rs 318.6 crore | 204.7 crore (Q4 FY25) |
| Revenue from Operations | Rs 2,064.9 crore | 1,828.5 crore (Q4 FY25) |
| Dividend | Rs 9 per share | Subject to AGM approval |
| NSE Ticker | SHARDACROP | Sector: Agrochemicals |
Screen the best stocks on the Univest Screener.
Sharda Cropchem Q4 FY26 Performance Analysis
Sharda Cropchem Q4 FY26 consolidated PAT rose 56% YoY to Rs 318.6 crore on revenue of Rs 2,064.9 crore (+13% YoY). Agrochemicals segment revenue Rs 1,926.8 crore, profit Rs 379.9 crore. FY26 full-year performance was record-breaking: PAT surged 124% to Rs 681 crore from Rs 304.4 crore in FY25, revenue up 22% to Rs 5,267.6 crore. Gross margin expanded 600bps to 35.9%. EBITDA Rs 1,040 crore (+69% YoY). Active registrations 3,011 across 80+ countries. Board recommended final dividend of Rs 9/share. FY26 EPS Rs 75.47 vs Rs 33.74. Investors and analysts will closely monitor management commentary on FY27 revenue outlook, margin trajectory, and capital allocation strategy following these Sharda Cropchem Q4 FY26 results.
The Sharda Cropchem Q4 FY26 results represent a strong growth quarter for the company. Track live price, analyst ratings, and earnings updates on the Univest Screener.
Sharda Cropchem FY27 Outlook
Post Sharda Cropchem Q4 FY26 results, investor focus for FY27 will be on management guidance, margin trajectory, new order wins or business development, and sector-specific tailwinds. The strong Q4 FY26 performance sets a positive base for FY27 earnings delivery.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Frequently Asked Questions on Sharda Cropchem Q4 FY26 Results
What is Sharda Cropchem Q4 FY26 net profit?
Ans. Sharda Cropchem Q4 FY26 net profit is Rs 318.6 crore, up 56 percent YoY.
When did Sharda Cropchem announce Q4 FY26 results?
Ans. Sharda Cropchem announced Q4 FY26 results on 13 May 2026, through its board meeting and BSE/NSE exchange filings.
What is Sharda Cropchem Q4 FY26 dividend?
Ans. The board recommended a final dividend of Rs 9 per equity share for FY26, subject to shareholder approval at the AGM.
Where can I track Sharda Cropchem Q4 FY26 live data?
Ans. Track Sharda Cropchem live price, analyst ratings, and Q4 FY26 earnings updates on the Univest Screener for real-time data and research.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. All financial data cited is sourced from BSE/NSE exchange filings and verified news sources. Investments in securities are subject to market risk. Consult a SEBI-registered investment advisor before making any investment decision.
Related Posts
ZF Commercial Vehicle Control Systems India Q4 FY26 Results: Consolidated PAT Rs 146.32 Crore Dividend Rs 4 Per Share
Laxmi India Finance Q4 FY26 Results: PAT Rs 20.5 Crore Up 40.4 Percent Revenue Rs 92.8 Crore Up 24.9 Percent
Black Rose Industries Q4 FY26 Results: Consolidated PAT Rs 9.40 Crore Soars
GlaxoSmithKline Pharmaceuticals India Q4 FY26 Results: PAT Rs 277.86 Crore Up 5.7 Percent Dividend Rs 57 Per Share Record Date May 29
Panth Infinity Q4 FY26 Results: Revenue Rs 59.85 Crore Up 294 Percent YoY FY26 Revenue Rs 282.09 Crore Up 841 Percent

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →